Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Osteoporosis Drugs Market Growth in 2025?

In recent times, the osteoporosis drugs market has seen a consistent expansion. It’s projected to expand from $12.33 billion in 2024 to $12.8 billion in 2025, yielding a compound annual growth rate (CAGR) of 3.8%. The notable growth observed in the past is ascribed to factors such as an aging population, heightened awareness and diagnosis, lifestyle influences, governmental endeavors, and health care regulations.

What Is the Forecast for the Osteoporosis Drugs Market Size Through 2029?

The market size for osteoporosis drugs is projected to exhibit consistent growth in the coming years, reaching $14.48 billion in 2029 with a compound annual growth rate (CAGR) of 3.1%. The expansion during this projected period can be credited to the continued trends of an aging population, advancements in treatment methods, heightened attention on bone health in men, initiatives in patient education and empowerment, international health policies, and insurance provisions. Key trends anticipated during this period encompass the adoption of personalized medicine, the investigation into combined therapies, a strong emphasis on preventative measures against fractures, investment in research and development of innovative drug targets, and collaborations in the realm of drug development.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp

What are the Key Market Players in Osteoporosis Drugs Market and How They’re Evolving?

Major companies operating in the osteoporosis drugs market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healthcare Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc.

What Are the Primary Growth Drivers in the Osteoporosis Drugs Market?

The rise in the incidence of osteoporosis is anticipated to amplify the expansion of the osteoporosis drug market. Osteoporosis, a bone condition that is characterized by a reduction in bone mineral density and bone mass or changes in the quality or structure of the bone, is more common among individuals with a low calcium intake. These drugs used to treat osteoporosis work by enhancing bone mineral density and averting fractures. In context, data from the Australian Institute of Health and Welfare Australia-Government agency in June 2024 revealed that in 2022, osteoporosis was the cause of 2,659 fatalities, equating to 10.2 deaths for every 100,000 people, accounting for 1.4% of all deaths. It is, thus, clear that the rising incidence of osteoporosis is fueling the expansion of the osteoporosis drugs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9102&type=smp

What Are the Leading Segments in the Global Osteoporosis Drugs Industry?

The osteoporosis drugs market covered in this report is segmented –

1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors

2) By Administration: Oral, Injectable

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales

4) By Application: Primary Osteoporosis, Secondary Osteoporosis

Subsegments:

1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid

2) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene

3) By RANK Ligand Inhibitors: Denosumab

What Are the Key Market Trends in the Osteoporosis Drugs Industry?

Key players in the osteoporosis drugs market are making strides in adopting innovative solutions within the market. For instance, Apotex Inc., a pharmaceutical firm based in Canada, unveiled the Teriparatide Injectable for treating osteoporosis in November 2023. The teriparatide injection is a pre-loaded pen that contains 250 mcg/mL, capable of delivering 28 daily doses of 20 mcg per pen and is meant for single-patient use. It is anticipated that this product will afford patients the much-needed access at a reasonable cost.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

What Is the Regional Outlook for the Osteoporosis Drugs Market?

North America was the largest region in the osteoporosis market in 2024. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9102

This Report Delivers Insight On:

1. How big is the osteoporosis drugs market, and how is it changing globally?

2. Who are the major companies in the osteoporosis drugs market, and how are they performing?

3. What are the key opportunities and risks in the osteoporosis drugs market right now?

4. Which products or customer segments are growing the most in the osteoporosis drugs market?

5. What factors are helping or slowing down the growth of the osteoporosis drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model